Navigation Links
EtQ’s Chief Technology Officer to Speak at INTERPHEX
Date:4/16/2013

Farmingdale, NY (PRWEB) April 16, 2013

EtQ is pleased to announce that its CTO, Morgan Palmer, will be speaking at INTERPHEX, to be held from April 23st to 25th in New York, NY.

Palmer will present the topic, “Establishing a Quality Agreement with a Unified Approach for all Suppliers,” at 10:15 am on Wednesday, April 24th.

“It is important to understand the various elements that can arise as a result of poor supply chain quality,” stated Palmer. “This session will explain these elements and will discuss the benefits of extending the quality system to suppliers, such as real-time risk management in the supply chain. Ultimately, what attendees will take away from this session is an understanding of the need for harmonizing quality agreements for suppliers as well as the best practices in extending the quality system to the supply chain.”

EtQ will also be exhibiting at INTERPHEX. For more information, visit us in booth 1861, or on the Web at http://www.etq.com. In addition, EtQ is offering a 50 percent discount on conference registration. Register here to receive this discount on either one- or two-day conference packages. This will provide access to all INTERPHEX Conference sessions including keynotes, technical workshops, special Thursday presentations, lunch on Tuesday and/or Wednesday as well as access to the show floor.

About INTERPHEX
INTERPHEX is the leading annual pharmaceutical and biopharmaceutical trade show. Key decision makers find the networking opportunities, products, services and information they need to ensure quality and maximize efficiency, agility, and flexibility that solve manufacturing and supply chain problems. INTERPHEX is where intelligence and passion intersect with the full spectrum of industry products and services to create new insights and innovation.

About EtQ
EtQ is the leading FDA Compliance, Quality, EHS, and Operational Risk Management software provider for identifying, mitigating and preventing high-risk events through integration, automation and collaboration. Founded in 1992, EtQ has always had a unique knowledge of FDA Compliance, Quality, EHS, and Operational Risk processes, and strives to make overall quality operations and management systems better for businesses. EtQ is headquartered in Farmingdale, NY, with main offices located in EMEA, the UK, and Arizona. EtQ has been providing software solutions to a variety of markets for more than 20 years. For more information, please visit http://www.etq.com or contact us at 800-354-4476.

EtQ is a trademark of EtQ Management Consultants, Inc. All other product names and company names are trademarks or registered trademarks of their respective owners.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10633650.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Veracyte Announces Appointment of Shelly D. Guyer as Chief Financial Officer
2. PI hires William Culpi as Engineering Chief - PI miCos USA Products by PI USA
3. GenoSpace Expands Its Management Team by Appointing Daniel Meyer as Chief Financial Officer
4. CardioWise™ Welcomes Geoffrey Dalbow as Chief Technology Officer
5. DuPont Joins Israel’s Office of the Chief Scientist Global Enterprise R&D Cooperation Framework
6. Clinical Immunology Society Appoints Vincent Bonagura, MD as Editor-in-Chief of the Journal of Clinical Immunology
7. Elsevier Names Dr. Jim Nolin Editor-in-Chief of Order Set Solution
8. Janet Kreizman Appointed Chief Executive Officer of AACC
9. Lou Paradise, President and Chief of Research, Topical BioMedics, Inc. Slated to Speak at Integrative Healthcare Symposium
10. Inflamax Research Appoints Dr. Anne Marie Salapatek President & Chief Scientific Officer
11. ABIA Hires Biomedical Executive, Serial Entrepreneur as Chief Operating Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 On Wednesday, ... at 4,833.32, down 0.22%; the Dow Jones Industrial Average edged ... closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on ... ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals ... (NASDAQ: BIND ). Learn more about these stocks ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® ... provides a free webinar on Performing Quality Investigations: Getting to Root ... CT at no charge. , Incomplete investigations are still a major concern to ...
(Date:6/23/2016)... -- Amgen (NASDAQ: AMGN ) today announced a ... sciences incubator to accelerate the development of new therapies ... QB3@953 was created to help high-potential life science and ... stage organizations - access to laboratory infrastructure. ... "Amgen Golden Ticket" awards, providing each winner with one ...
(Date:6/22/2016)... SAN DIEGO , June 22, 2016 /PRNewswire/ ... partnership that will allow them to produce up ... (HiPSC) from one lot within one week. These ... their time laboriously preparing cells and spend more ... made possible through a proprietary, high-volume manufacturing process ...
Breaking Biology Technology:
(Date:6/2/2016)... 2016 The Department of Transport Management ... 44 million US Dollar project, for the , ... Personalization, Enrolment, and IT Infrastructure , to ... and implementation of Identity Management Solutions. Numerous renowned international vendors ... Decatur was selected for the most compliant and ...
(Date:5/20/2016)...  VoiceIt is excited to announce its new ... By working together, VoiceIt and VoicePass will offer ... take slightly different approaches to voice biometrics, collaboration ... usability. Both ... "This marketing and technology partnership allows ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 /PRNewswire/ ... product subsidiary of Infosys (NYSE: INFY ), and ... global partnership that will provide end customers with ... banking and payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ... area for financial services, but it also plays a fundamental ...
Breaking Biology News(10 mins):